David van Heel
Research Theme: Genomic Medicine
I did a Natural Sciences BA at Cambridge University in 1990 and completed Clinical Medicine training at University of Oxford in 1993. A Medical Research Council Clinical Training Fellowship led to a DPhil from the Wellcome Trust Centre for Human Genetics, University of Oxford in 2002. I was then a Wellcome Trust Clinician Scientist Fellow at Imperial College London from 2002 to 2006. I completed specialist medical training as a Consultant in Gastroenterology in 2004.
Research
My main research interests are the genetic causes of coeliac disease, Crohn's disease and type 1 diabetes, and the functional/immunological consequences of these genetic variants on human biology.
Achievements include:
- Demonstrating that Crohn's disease associated NOD2 variants are loss of function in human cells (2005).
- Performing the first genome wide association study in coeliac disease, identifying variants in the IL2-IL21 region (2007).
- Identifying a further seven coeliac disease associated gene regions (2008). Interestingly many regions are shared with other autoimmune diseases (e.g. type 1 diabetes, 2008), mostly with the same SNP allele but in some cases a different SNP or with the alternate SNP allele.
- Establishing high-throughput sequencing at the Barts and The London Genome Centre (2008/9).
- Developing a new method to understand the function of disease associated genetic variants: high throughput Illumina GAII sequencing for allele specific expression (2009). As proof of principle, we show that multiple sclerosis risk variants in CD6 alter the level of CD6 expression.
I have current or recent funding and/or support from:
- Juvenile Diabetes Research Foundation
- Medical Research Council
- Wellcome Trust
- Coeliac UK.
Recent and ongoing research projects:
- Genetic risk factors for coeliac disease
- Shared and distinct genetic risk factors across the different chronic immune diseases
- Understanding how chronic immune disease genetic risk factors alter (human) immuno-biology
- Towards new diagnostics and therapeutics for chronic immune diseases, based on advances in understanding the genetic basis of disease
Publications
Key Publications
Hunt KA, Smyth DJ, Balschun T, Ban M, Mistry V, Ahmad T, Anand V, Barrett JC, Bhaw-Rosun L, Bockett NA, Brand OJ, Brouwer E, Concannon P, Cooper JD, Dias KR, van Diemen CC, Dubois PC, Edkins S, Fölster-Holst R, Fransen K, Glass DN, Heap GA, Hofmann S, Huizinga TW, Hunt S, Langford C, Lee J, Mansfield J, Marrosu MG, Mathew CG, Mein CA, Müller-Quernheim J, Nutland S, Onengut-Gumuscu S, Ouwehand W, Pearce K, Prescott NJ, Posthumus MD, Potter S, Rosati G, Sambrook J, Satsangi J, Schreiber S, Shtir C, Simmonds MJ, Sudman M, Thompson SD, Toes R, Trynka G, Vyse TJ, Walker NM, Weidinger S, Zhernakova A, Zoledziewska M; Type 1 Diabetes Genetics Consortium; UK Inflammatory Bowel Disease (IBD) Genetics Consortium; Wellcome Trust Case Control Consortium, Weersma RK, Gough SC, Sawcer S, Wijmenga C, Parkes M, Cucca F, Franke A, Deloukas P, Rich SS, Todd JA, van Heel DA. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet. 2012;44(1):3-5. doi: 10.1038/ng.1037. PubMed PMID: 22200769; PubMed Central PMCID: PMC3287292.
Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, Bakker SF, Bardella MT, Bhaw-Rosun L, Castillejo G, de la Concha EG, de Almeida RC, Dias KR, van Diemen CC, Dubois PC, Duerr RH, Edkins S, Franke L, Fransen K, Gutierrez J, Heap GA, Hrdlickova B, Hunt S, Izurieta LP, Izzo V, Joosten LA, Langford C, Mazzilli MC, Mein CA, Midah V, Mitrovic M, Mora B, Morelli M, Nutland S, Núñez C, Onengut-Gumuscu S, Pearce K, Platteel M, Polanco I, Potter S, Ribes-Koninckx C, Ricaño-Ponce I, Rich SS, Rybak A, Santiago JL, Senapati S, Sood A, Szajewska H, Troncone R, Varadé J, Wallace C, Wolters VM, Zhernakova A; Spanish Consortium on the Genetics of Coeliac Disease (CEGEC); PreventCD Study Group; Wellcome Trust Case Control Consortium (WTCCC), Thelma BK, Cukrowska B, Urcelay E, Bilbao JR, Mearin ML, Barisani D, Barrett JC, Plagnol V, Deloukas P, Wijmenga C, van Heel DA. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011 Nov 6;43(12):1193-201. doi: 10.1038/ng.998. PubMed PMID: 22057235; PubMed Central PMCID: PMC3242065.
Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, O'Toole EA, Martin JE, Lindley K, Vulliamy T, Abrams DJ, MacDonald TT, Harper JI, Kelsell DP. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med. 2011 Oct 20;365(16):1502-8. PubMed PMID: 22010916.
Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, Zhernakova A, Heap GA, Adány R, Aromaa A, Bardella MT, van den Berg LH, Bockett NA, de la Concha EG, Dema B, Fehrmann RS, Fernández-Arquero M, Fiatal S, Grandone E, Green PM, Groen HJ, Gwilliam R, Houwen RH, Hunt SE, Kaukinen K, Kelleher D, Korponay-Szabo I, Kurppa K, MacMathuna P, Mäki M, Mazzilli MC, McCann OT, Mearin ML, Mein CA, Mirza MM, Mistry V, Mora B, Morley KI, Mulder CJ, Murray JA, Núñez C, Oosterom E, Ophoff RA, Polanco I, Peltonen L, Platteel M, Rybak A, Salomaa V, Schweizer JJ, Sperandeo MP, Tack GJ, Turner G, Veldink JH, Verbeek WH, Weersma RK, Wolters VM, Urcelay E, Cukrowska B, Greco L, Neuhausen SL, McManus R, Barisani D, Deloukas P, Barrett JC, Saavalainen P, Wijmenga C, van Heel DA. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010 Apr;42(4):295-302. Epub 2010 Feb 28. PubMed PMID: 20190752; PubMed Central PMCID: PMC2847618.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008 Dec 25;359(26):2767-77. Epub 2008 Dec 10. PubMed PMID: 19073967; PubMed Central PMCID: PMC2840835.
Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, O'Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, Mein CA, Wapenaar MC, Deloukas P, McGinnis R, McManus R, Wijmenga C, van Heel DA. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008 Apr;40(4):395-402. Epub 2008 Mar 2. PubMed PMID: 18311140; PubMed Central PMCID: PMC2673512.
van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, Wapenaar MC, Barnardo MC, Bethel G, Holmes GK, Feighery C, Jewell D, Kelleher D, Kumar P, Travis S, Walters JR, Sanders DS, Howdle P, Swift J, Playford RJ, McLaren WM, Mearin ML, Mulder CJ, McManus R, McGinnis R, Cardon LR, Deloukas P, Wijmenga C. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007 Jul;39(7):827-9. Epub 2007 Jun 10. PubMed PMID: 17558408; PubMed Central PMCID: PMC2274985.
van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, McGovern DP, Onnie C, Negoro K, Goldthorpe S, Foxwell BM, Mathew CG, Forbes A, Jewell DP, Playford RJ. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet. 2005 May 21-27;365(9473):1794-6. PubMed PMID: 15910952.
All publications from PubLists
10.1038/ng.1037
10.1371/journal.pgen.1002431
10.1038/ng.998
10.1101/gr.121640.111
10.1056/NEJMoa1100721
10.1016/j.ajhg.2011.09.001
10.1093/bioinformatics/btr323
10.1371/journal.pgen.1002254
10.1371/journal.pgen.1002197
10.4049/jimmunol.1000085
10.1371/journal.pgen.1001283
10.1016/j.molmed.2010.09.003
10.1126/scitranslmed.3001012
10.1016/j.ajhg.2010.05.004
10.1038/ng.543
10.1093/hmg/ddp473
10.1016/j.smim.2009.04.001
10.1038/ng.467
10.1093/hmg/ddp365
10.1093/hmg/ddp364
10.1053/j.gastro.2009.05.040
10.1136/gut.2008.169052
10.1093/hmg/ddp001
10.1136/gut.2008.155879
10.1093/hmg/ddn438
10.1038/ajg.2009.16
10.1186/1755-8794-2-1
10.1111/j.1365-2249.2008.03704.x
10.1038/gene.2008.27
10.1016/j.ajhg.2008.05.008
10.1038/ng0608-686
10.1016/j.ajhg.2008.03.016
10.1053/j.gastro.2008.03.068
10.1136/gut.2007.133132
10.1038/ng.102
10.1371/journal.pone.0002270
10.1016/j.crohns.2007.08.006
10.1086/522037
10.2353/ajpath.2007.070192
10.1038/ng2058
10.1016/j.immuni.2007.05.015
10.1164/rccm.200608-1103OC
10.1053/j.gastro.2006.09.011
10.1359/jbmr.060721
10.1053/j.gastro.2006.08.008
10.1002/eji.200636631
10.1097/01.ibd.0000225344.21979.89
10.1136/gut.2005.086769
10.1136/gut.2005.075119
10.1002/eji.200535636
10.1136/gut.2005.064550
10.1136/gut.2005.079335
10.1002/eji.200535497
10.1136/gut.2005.065888
10.1136/gut.2004.062588
10.1136/gut.2004.059998
10.1002/eji.200526296
10.1016/j.bpg.2005.01.001
10.1016/S0140-6736(05)66582-8
10.1093/hmg/ddi135
10.1038/sj.ejhg.5201357
10.1242/jcs.01043
10.1093/hmg/ddh090
10.1055/s-2004-814253
10.1086/379745
10.1093/hmg/ddg281
10.1002/ajmg.10588
10.1002/art.10329
10.1038/sj.gene.6363810
10.1038/sj.ejhg.5200687
10.1016/S0140-6736(00)05091-1
10.1086/320119

